Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorAWAN, Ahmed Arslan Yousuf
dc.contributor.authorBERENGUER, Marina C.
dc.contributor.authorBRUCHFELD, Annette
dc.contributor.authorFABRIZI, Fabrizio
dc.contributor.authorGOLDBERG, David S.
dc.contributor.authorJIA, Jidong
dc.contributor.authorKAMAR, Nassim
dc.contributor.authorMOHAMED, Rosmawati
dc.contributor.authorPESSOA, Mario Guimaraes
dc.contributor.authorPOL, Stanislas
dc.contributor.authorSISE, Meghan E.
dc.contributor.authorBALK, Ethan M.
dc.contributor.authorGORDON, Craig E.
dc.contributor.authorADAM, Gaelen
dc.contributor.authorCHEUNG, Michael
dc.contributor.authorEARLEY, Amy
dc.contributor.authorMARTIN, Paul
dc.contributor.authorJADOUL, Michel
dc.date.accessioned2024-04-05T19:39:27Z
dc.date.available2024-04-05T19:39:27Z
dc.date.issued2023
dc.description.abstractDescription: The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 clinical practice guideline on prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease (CKD) is an update of the 2018 guideline from KDIGO.Methods: The KDIGO Work Group (WG) updated the guideline, which included reviewing and grading new evidence that was identified and summarized. As in the previous guideline, the WG used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to appraise evidence and rate the strength of recommendations and used expert judgment to develop recommendations. New evidence led to updating of recommendations in the chapters on treatment of hepatitis C virus (HCV) infection in patients with CKD (Chapter 2), management of HCV infection before and after kidney transplant (Chapter 4), and diagnosis and management of kidney disease associated with HCV infection (Chapter 5). Recommendations in chapters on detection and evaluation of hepatitis C in CKD (Chapter 1) and prevention of HCV transmission in hemodialysis units (Chapter 3) were not updated because of an absence of significant new evidence.Recommendations: The 2022 updated guideline includes 43 graded recommendations and 20 ungraded recommendations, 7 of which are new or modified on the basis of the most recent evidence and consensus among the WG members. The updated guidelines recommend expanding treatment of hepatitis C with sofosbuvir-based regimens to patients with CKD glomerular filtration rate categories G4 and G5, including those receiving dialysis; expanding the donor pool for kidney transplant recipients by accepting HCV-positive kidneys regardless of the recipient's HCV status; and initiating direct-acting antiviral treatment of HCV-infected patients with clinical evidence of glomerulonephritis without requiring kidney biopsy. The update also addresses the use of immunosuppressive regimens in such patients.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexScopus
dc.description.indexDimensions
dc.description.indexWoS
dc.description.sponsorshipKDIGO
dc.identifier.citationANNALS OF INTERNAL MEDICINE, v.176, n.12, p.1648-1655, 2023
dc.identifier.doi10.7326/M23-2391
dc.identifier.eissn1539-3704
dc.identifier.issn0003-4819
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/59195
dc.language.isoeng
dc.publisherAMER COLL PHYSICIANSeng
dc.relation.ispartofAnnals of Internal Medicine
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright AMER COLL PHYSICIANSeng
dc.subject.otherrandomized controlled-trialeng
dc.subject.otherantiviral prophylaxiseng
dc.subject.otherviruseng
dc.subject.othertransplantationeng
dc.subject.otherrituximabeng
dc.subject.othercirrhosiseng
dc.subject.wosMedicine, General & Internaleng
dc.titlePrevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guidelineeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countrySuécia
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryBélgica
hcfmusp.affiliation.countryMalásia
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryChina
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisose
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisocn
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisomy
hcfmusp.affiliation.countryisobe
hcfmusp.author.externalAWAN, Ahmed Arslan Yousuf:Baylor Coll Med, Selzman Inst Kidney Hlth, Dept Med, Sect Nephrol, Houston, TX USA
hcfmusp.author.externalBERENGUER, Marina C.:Univ Valencia, Dept Gastroenterol, Hepatol Unit, Valencia, Spain; Univ Valencia, Hosp Univ & Politecn La Fe, Inst Invest La Fe, Valencia, Spain; Ctr Invest Biomed Red Enfermedades Hepat & Digest, Valencia, Spain; Univ Valencia, Sch Med, Valencia, Spain
hcfmusp.author.externalBRUCHFELD, Annette:Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden; Karolinska Univ Hosp, Dept Renal Med, Stockholm, Sweden; CLINTEC Karolinska Inst, Stockholm, Sweden
hcfmusp.author.externalFABRIZI, Fabrizio:Maggiore Policlin Hosp, Div Nephrol, Milan, Italy; IRCCS Ca Granda Fdn, Milan, Italy
hcfmusp.author.externalGOLDBERG, David S.:Univ Miami, Div Digest Hlth & Liver Dis, Sch Med, Miami, FL USA
hcfmusp.author.externalJIA, Jidong:Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, Beijing, Peoples R China; Beijing Key Lab Transit Med Liver Cirrhosis, Beijing, Peoples R China; Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China
hcfmusp.author.externalKAMAR, Nassim:Univ Paul Sabatier, INSERM, U1043, CHU Rangueil,IFR BMT,Dept Nephrol, Toulouse, France; Univ Paul Sabatier, INSERM, U1043, CHU Rangueil,IFR BMT,Dept Organ Transplantat, Toulouse, France
hcfmusp.author.externalMOHAMED, Rosmawati:Univ Malaya, Med Ctr, Dept Med, Kuala Lumpur, Malaysia
hcfmusp.author.externalPOL, Stanislas:Paris Descartes Univ, Hop Cochin, AP HP, Hepatol Dept,INSERM,U1223,Inst Pasteur, Paris, France
hcfmusp.author.externalSISE, Meghan E.:Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA
hcfmusp.author.externalBALK, Ethan M.:Brown Univ, Sch Publ Hlth, Ctr Evidence Synth Hlth, Providence, RI 02912 USA
hcfmusp.author.externalGORDON, Craig E.:Tufts Med Ctr, Div Nephrol, Boston, MA 02111 USA
hcfmusp.author.externalADAM, Gaelen:Brown Univ, Sch Publ Hlth, Ctr Evidence Synth Hlth, Providence, RI 02912 USA
hcfmusp.author.externalCHEUNG, Michael:KDIGO, Brussels, Belgium
hcfmusp.author.externalEARLEY, Amy:KDIGO, Brussels, Belgium
hcfmusp.author.externalMARTIN, Paul:Univ Miami, Div Digest Hlth & Liver Dis, Sch Med, Miami, FL USA
hcfmusp.author.externalJADOUL, Michel:Catholic Univ Louvain, Clin St Luc, Dept Nephrol, Brussels, Belgium
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcMARIO GUIMARAES PESSOA
hcfmusp.description.beginpage1648
hcfmusp.description.endpage1655
hcfmusp.description.issue12
hcfmusp.description.volume176
hcfmusp.origemWOS
hcfmusp.origem.dimensionspub.1166933461
hcfmusp.origem.pubmed38079642
hcfmusp.origem.scopus2-s2.0-85180410803
hcfmusp.origem.wosWOS:001129177500001
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUNITED STATESeng
hcfmusp.relation.referenceAwan AA, 2020, CLIN GASTROENTEROL H, V18, P2158, DOI 10.1016/j.cgh.2019.07.050eng
hcfmusp.relation.referenceBalk EM, 2023, KIDNEY INT REP, V8, P240, DOI 10.1016/j.ekir.2022.11.008eng
hcfmusp.relation.referenceBorgia SM, 2019, J HEPATOL, V71, P660, DOI 10.1016/j.jhep.2019.05.028eng
hcfmusp.relation.referenceBrouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449eng
hcfmusp.relation.referenceDaloul R, 2020, AM J TRANSPLANT, V20, P1463, DOI 10.1111/ajt.15788eng
hcfmusp.relation.referenceDe Vita S, 2012, ARTHRITIS RHEUM-US, V64, P843, DOI 10.1002/art.34331eng
hcfmusp.relation.referenceDurand CM, 2018, ANN INTERN MED, V168, P533, DOI 10.7326/M17-2871eng
hcfmusp.relation.referenceEuropean Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021eng
hcfmusp.relation.referenceGoldberg DS, 2017, NEW ENGL J MED, V376, P2394, DOI 10.1056/NEJMc1705221eng
hcfmusp.relation.referenceGordon CE, 2023, AM J KIDNEY DIS, V82, P410, DOI 10.1053/j.ajkd.2022.12.019eng
hcfmusp.relation.referenceGordon CE, 2019, ANN INTERN MED, V171, P496, DOI 10.7326/M19-1539eng
hcfmusp.relation.referenceGupta G, 2021, AM J TRANSPLANT, V21, P3734, DOI 10.1111/ajt.16747eng
hcfmusp.relation.referenceGuyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011eng
hcfmusp.relation.referenceJadoul M, 2022, KIDNEY INT, V102, pS129, DOI 10.1016/j.kint.2022.07.013eng
hcfmusp.relation.referenceKasuno K, 2003, AM J KIDNEY DIS, V41, P767, DOI 10.1016/S0272-6386(03)00024-6eng
hcfmusp.relation.referenceKirby BJ, 2015, CLIN PHARMACOKINET, V54, P677, DOI 10.1007/s40262-015-0261-7eng
hcfmusp.relation.referenceKucirka LM, 2010, AM J TRANSPLANT, V10, P1238, DOI 10.1111/j.1600-6143.2010.03091.xeng
hcfmusp.relation.referenceLawitz E, 2020, LANCET GASTROENTEROL, V5, P918, DOI 10.1016/S2468-1253(19)30417-0eng
hcfmusp.relation.referenceMoberg J, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0320-2eng
hcfmusp.relation.referenceNahon P, 2017, GASTROENTEROLOGY, V152, P142, DOI 10.1053/j.gastro.2016.09.009eng
hcfmusp.relation.referencede José AP, 2021, CLIN KIDNEY J, V14, P586, DOI 10.1093/ckj/sfz178eng
hcfmusp.relation.referencePol S, 2017, ALIMENT PHARM THER, V46, P1054, DOI 10.1111/apt.14352eng
hcfmusp.relation.referencePol S, 2004, HUM PATHOL, V35, P107, DOI 10.1016/j.humpath.2003.08.012eng
hcfmusp.relation.referenceReese PP, 2018, ANN INTERN MED, V169, P273, DOI 10.7326/M18-0749eng
hcfmusp.relation.referenceSchaubel DE, 2022, JAMA-J AM MED ASSOC, V328, P1102, DOI 10.1001/jama.2022.12868eng
hcfmusp.relation.referenceSneller MC, 2012, ARTHRITIS RHEUM-US, V64, P835, DOI 10.1002/art.34322eng
hcfmusp.relation.referenceTerrault Norah A, 2018, Hepatology, V67, P1560, DOI [10.1002/cld.728, 10.1002/hep.29800]eng
hcfmusp.relation.referenceTorabi J, 2021, TRANSPL INFECT DIS, V23, DOI 10.1111/tid.13449eng
hcfmusp.relation.referenceWheeler DC, 2018, KIDNEY INT SUPPL, V8, P91, DOI 10.1016/j.kisu.2018.06.001eng
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublication0baf66bd-afb9-4844-b40c-485b3c558f66
relation.isAuthorOfPublication.latestForDiscovery0baf66bd-afb9-4844-b40c-485b3c558f66
Arquivos
Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC